Targeted Antibody Cancer Treatment CEO on RSR

This is the show from Friday, February 10th, 2017

SUMMARY:

* ArcherDX in Boulder, Colorado: ArcherDX spearheaded the effort to save the life of 12-year old Zaida. Real Science Radio host Bob Enyart interviews Archer's CEO Jason Myers to discuss Zaida's case and to get a better understanding both of this revolution in cancer treatment and of how targeted immunotherapy work. Studies in the U.S. and the U.K. are seeing hundreds of patients with many types of cancer virtually "cured", as some oncologists are now putting it. Not every patient though responds well, but the widespread success is stunning! ArcherDX provides the technology so that a patient's doctor can find out quickly what specific mutations may be causing the cancer. Now, a growing number of oncologists will be offering their patients the greatest of hope through individualized treatment that, like an archer aiming at a target, just might hit the bullseye! Online at ArcherDX.com, this next-generation sequencing (NGS) firm develops what is called target enrichment chemistry.



* rsr.org/targeted-antibodies: For more about the stunning targeted antibody revolution in cancer treatment see rsr.org/targeted-antibodies.